beta-Amyloid Ca(2+)-channel hypothesis for neuronal death in Alzheimer disease.
The Alzheimer's Disease (AD) amyloid protein (A beta P[1-40]) forms cation selective channels when incorporated into planar lipid bilayers by fusion with liposomes containing the peptide. Since the peptide has been proposed to occur in vivo in both membrane-bound and soluble forms, we also tested the possibility of direct incorporation of the soluble A beta P[1-40] into the membrane. We found the peptide can also form similar channels in acidic phospholipid bilayers formed at the tip of a patch pipet, as well as in the planar lipid bilayer system. As in the case of liposome mediated incorporation, the A beta P[1-40]-channel in the solvent-free membrane patch exhibits multiple cation selectivity (Cs+ > Li+ > Ca2+ > or = K+), and sensitivity to tromethamine. The fact that equivalent A beta P[1-40] amyloid channels can be detected by two different methods thus provides additional validation of our original observation. Further studies with a beta P-channels incorporated into planar lipid bilayers from the liposome complex have also revealed that the channel activity can express spontaneous transitions to a much higher range of conductances between 400 and 4000 pS. Under these conditions, the amyloid channel continues to be cation selective but loses its tromethamine sensitivity. By contrast, amyloid channels were insensitive to nitrendipine at either conductance range. We calculate that if such channels were expressed in cells, the ensuing ion fluxes down their electrochemical potential gradients would disrupt cellular homeostasis. We therefore interpret these data as providing further support for our beta-amyloid Ca(2+)-channel hypothesis for neuronal death in Alzheimer's Disease.
Arispe
N
N
Laboratory of Cell Biology and Genetics, NIDDK, National Institutes of Health, Bethesda, MD 20892.
Pollard
H B
HB
Rojas
E
E
D000544:Alzheimer Disease / Q000473:pathology* / Q000503:physiopathology*; D016229:Amyloid beta-Peptides / Q000502:physiology*; D000818:Animals; D001921:Brain / Q000473:pathology / Q000503:physiopathology*; D015220:Calcium Channels / Q000502:physiology*; D002412:Cations / Q000378:metabolism; D016923:Cell Death; D002462:Cell Membrane / Q000502:physiology; D006801:Humans; D008051:Lipid Bilayers; D008564:Membrane Potentials; D008959:Models, Neurological; D009474:Neurons / Q000473:pathology / Q000502:physiology*; D010743:Phospholipids / Q000502:physiology
D016229:Amyloid beta-Peptides; D015220:Calcium Channels; D002412:Cations; D008051:Lipid Bilayers; D010743:Phospholipids